Professor Hak-Kim Chan
Professor Hak-Kim Chan is leading the Respiratory Research Theme and the Advanced Drug Delivery Group at the Faculty of Pharmacy. He graduated from the University of Sydney (Ph.D. 1988 and D.Sc. 2009), was a postdoc at the University of Minnesota in 1988 – 1989 and a scientist at Genentech Inc in 1992 – 1995. His research, funded primarily by the Australian Research Council, focuses on inhalation drug delivery, ranging from powder production by novel processes, particle engineering and aerosol formulation to scintigraphic imaging of lung deposition and clinical outcomes. He has over 250 scientific publications on pharmaceutical formulation and drug delivery (with over 4500 citations and h-index 36) and holds seven patents in these areas. He is an executive editor of Advanced Drug Delivery Reviews and on the editorial advisory boards of various pharmaceutical journals including Pharmaceutical Research and International Journal of Pharmaceutics. He was appointed to the Subcommittee on Pharmaceutical Aerosol Standards for the Australian Therapeutic Goods Administration in 1996–97, and served as a member (2007 – 2008) on the in vitro – in vivo correlation subgroup of the International Pharmaceutical Aerosol Consortium on Regulation and Science in Washington DC. He is a Fellow of the American Association of Pharmaceutical Scientists (AAPS), Fellow of Royal Australian Chemical Institute (RACI), Chair of the NSW Pharmaceutical Science Group of the RACI, and Vice President of the Asian Federation for Pharmaceutical Sciences.
Kim is particularly interested in translating his inhalation drug delivery knowledge to tackling respiratory infections such as influenza, tuberculosis and bacterial infections in various settings including critically ill patients at the intensive care units.
You can view his full profile at Faculty of Pharmacy.
We welcome Kim to the SEIB/SIBRN team.